Dioleylphosphatidylglycerol inhibits the expression of type II phospholipase A2 in macrophages

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 2, 1999, Pages 613-618

  Berger, Arnaud ^b   Havet, Nathalie ^b   Vial, Daniel ^b   Arbibe, Laurence ^b   Dumarey, Claude ^b   Watson, Malcom L ^b   Touqui, Lhousseine ^a  

^a INSTITUT PASTEUR   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIOLEYLPHOSPHATIDYLGLYCEROL; DIPALMITOYLPHOSPHATIDYLCHOLINE; LUNG SURFACTANT EXTRACT; PHOSPHATIDYLGLYCEROL; PHOSPHOLIPASE A2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SYNTHESIS; GUINEA PIG; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0000130386     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.2.9805053     Document Type: Article

References (30)

1. Van Den Bosh, H. 1980. Intracellular phospholipases A. Biochim. Biophys. Acta 604:191-210.
2. Mayer, R. J., and L. A. Marshall. 1993. New insights on mammalian phospholipase A2(s): comparison of arachidonoyl-selective and -non-selective enzymes. FASEB J. 7:339-348.
3. Dennis, E. A. 1997. The growing phospholipase A2 superfamily of signal transduction enzymes. TIBS 22:1-2.
4. Tischfield, J. A. 1997. A reassessment of the low molecular weight phospholipase A2 gene family in mammals. J. Biol. Chem. 272:17247-17250.
5. Kramer, R. M., C. Hession, B. Johasen, G. Hayes, P. McGray, E. P. Chow, R. Tizard, and R. B. Pepinsky. 1989. Structure and properties of a human non-pancreatic phospholipase A2. J. Biol. Chem. 264:5768-5773.
6. Hidi, R., B. B. Vargaftig, and L. Touqui. 1993. Increased synthesis and secretion of a 14 kDa phospholipase A2 by guinea-pig alveolar macrophages. J. Immunol. 151:5613-5623.
7. Vial, D., M. Senorale-Pose, N. Havet, L. Molio, B. B. Vargaftig, and L. Touqui. 1995. Expression of the type-II PLA2 in alveolar macrophages: down-regulation by an inflammatory signal. J. Biol. Chem. 270:17327-17332.
8. Pruzanski, W., and P. Vadas. 1991. Phospholipase A2 - a mediator between proximal and distal effectors of inflammation. Immunol. Today 12:143-147.
9. Arbibe, L., D. Vial, I. Rosinski-Chupin, N. Havet, M. Huerre, B. B. Vargaftig, and L. Touqui. 1997. Endotoxin induces expression of type II phospholipase A2 during acute lung injury in guinea pigs: involvement of TNF-α in lipopolysaccharide-induced type-II phospholipase A2 synthesis. J. Immunol. 159:391-400.
10. Arbibe, A., D. Vial, and L. Touqui. 1997. Phospholipase A2 and acute respiratory distress syndrome. In W. Uhl, T. J. Nevalainen, and M. W. Büchler, editors. Phospholipase A2, Basic and Clinical Aspects in Inflammatory Diseases: Progress in Surgery. Basel, Karger 24:79-87.
11. Lewis, J. F., and A. Lobe. 1993. Surfactant and the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 147:218-233.
12. Rooney, S. A. 1985. The surfactant system and lung phospholipid biochemistry. Am. Rev. Respir. Dis. 131:439-460.
13. Collaborative European Multicenter Study Group. 1988. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Pediatrics Sd. 82:683-691.
14. Van Iwaarden, J. 1992. Surfactant and the pulmonary defense system. In B. Robertson, L. Van Golde, and J. Batenburg, editors. Pulmonary Surfactant: From Molecular Biology to Clinical Practice. Elsevier, Amsterdam. 215-254.
15. Thomassen, M. J., D. P. Meeker, J. M. Antal, M. J. Connors, and H. P. Wiedeman. 1992. Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 7:257-260.
16. Hayakawa, H., Q. N. Myrvik, and R. W. St. Clair. 1989. Pulmonary surfactant inhibits priming of rabbit alveolar macrophages. Am. Rev. Respir. Dis. 140:1390-1397.
17. Walti, H., B. S. Polla, and M. Bachelet. 1997. Modified natural surfactant inhibits superoxide anions and proinflammatory mediators released by resting and stimulated human monocytes. Pediatr. Res. 41:114-119.
18. Hidi, R., D. Vial, N. Havet, A. Berger, B. B. Vargaftig, and L. Touqui. 1997. Inhibition by pulmonary surfactant Curosurf of secretory phospholipase A2 expression in guinea-pig alveolar macrophages. Biochem. Pharmacol. 54:1055-1058.
19. White, A. M., T. Yoshimura, A. W. Smith, J. Westwick, and L. M. Watson. 1997. Airway inflammation induced by recombinant guinea pig tumor necrosis factor-α. Am. J. Physiol. 273:L524-L530.
20. Rooney, S. A., P. M. Canavan, and E. K. Motoyama. 1974. The identification of phosphatidylglycerol in the rat, rabbit, monkey and human lung. Biochim. Biophys. Acta 360:56-67.
21. Robertson, B., T. Curstedt, J. Johansson, H. Jörnvall, and T. Kobayashi. 1990. Structural and functional characterisation of porcine surfactant isolated by liquid-gel chromatography. Prog. Respir. Res. 25:237-246.
22. Radvanyi, F., L. Jordan, F. Russo-Maric, and C. Bon. 1989. A sensitive and continuous fluorometric assay for phospholipase A2 using pyrene-labelled phospholipids in the presence of serum albumin. Anal. Biochem. 177:103-107.
23. Schevitz, R. W., N. J. Bach, D. G. Carlson, N. Y. Chirgadze, D. K. Clawson, R. D. Dillard, S. E. Draheim, L. W. Hartley, N. D. Jones, E. D. Mihelich, J. L. Olkowsli, D. W. Snyder, C. Sommers, and J. P. Wery. 1995. Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2. Nat. Struct. Biol. 6:458-465.
24. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate phenol-chloroform extraction. Anal. Biochem. 162:156-159.
25. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
26. Church, G. M., and W. Gilbert. 1984. Genomic sequencing. Proc. Natl. Acad. Sci. U.S.A. 81:1991-1995.
27. Arbibe, L., K. Koumanov, D. Vial, C. Rougeot, G. Faure, N. Havet, S. Longacre, B. B. Vargaftig, G. Béréziat, D. R. Voelker, C. Wolf, and L. Touqui. 1998. Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction. J. Clin. Invest. 102:1152-1160
28. Eigler, A., B. Sinha, G. Hartmann, and S. Endres. 1997. Taming TNF: strategies to restrain this proinflammatory cytokine. Immunol. Today 18:487-492.
29. Walker, G., D. Kunz, W. Pignat, H. van den Bosch, and J. Pfeilschifter. 1995. Pyrrodiline dithiocarbamate differentially affects cytokine- and cAMP-induced expression of group-II phospholipase A2 in rat mesangial cells. FEBS Lett. 364:218-222.
30. Antal, J. M., L. T. Divis, C. Erzurum, H. P. Wiedmann, and M. J. Thomassen. 1996. Surfactant suppresses NF-κB activation in human monocytic cells. Am. J. Respir. Cell Mol. Biol. 14:374-379.